Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01932944 · ClinicalTrials.gov registry record
Accuracy Characterization Study
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 30
- Enrollment target
NCT01932944: Completed study, sponsored by Abbott Diabetes Care.
NCT01932944 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01932944 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
To demonstrate point accuracy of the Abbott Sensor Based Glucose Monitoring System (System) interstitial glucose results against venous glucose reference and capillary fingerstick using the Consensus Error Grid over the wear duration. During the course of the wear duration, the subject is required to be testing fingerstick glucose measurement at least 8 times a day for capillary reference glucose measurements and three in-clinic visits of maximum 10 hours each for venous reference glucose measurements. With every reference measurement, the subject or study staff will perform a measurement on the System.
Primary Outcome
To demonstrate point accuracy of the Abbott Sensor Based Glucose Monitoring (GM) System interstitial glucose results against venous glucose reference (YSI) using the Consensus Error Grid.
Interventions
- DEVICE No treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-03 |
What the finished NCT01932944 record still lists
NCT01932944 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No treatment is the first listed.
NCT01932944 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01932944 about?
NCT01932944 is a clinical study titled "Accuracy Characterization Study". To demonstrate point accuracy of the Abbott Sensor Based Glucose Monitoring System (System) interstitial glucose results against venous glucose reference and capillary fingerstick using the Consensus Error Grid over the wear duration. During the course of the wear duration, the subject is required t...
What is the current status of trial NCT01932944?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-08. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01932944?
The interventions under investigation include: No treatment (DEVICE).
Who is sponsoring clinical trial NCT01932944?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia